Navigation Links
Antidepressant helps obesity

Obesity is a disease and a growing health threat both in the USA and all over the world. The drug bupropion can help overweight and obese women lose weight in the long-term. It raises the risk of high blood pressure, diabetes, cancer and heart disease. Weight loss diets don't always work in the long term, and there has seen to be a need, now, to develop drugs which can handle obesity.//

Researchers at Harvard University in the USA have discovered that the drug bupropion, which is used for depression and smoking cessation, is helpful in helping women sustain weight loss. They gave 50 non-depressed overweight and obese women bupropion or placebo for eight weeks and put them on a 1,500 calorie per day diet. Two thirds of those on bupropion lost more than five per cent of their body weight, while only 15 per cent in the placebo group lost weight. They continued for another 16 weeks, after which time those on bupropion lost nearly 10 per cent of their body weight, on average, of which 70 per cent was fat. The benefits were maintained during two years of follow-up. It is not known how bupropion works in weight loss, although it's known to alter brain chemistry and may affect the appetite centres or circuits involved in getting pleasurable feelings from eating.


'"/>




Page: 1

Related medicine news :

1. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
2. Antidepressants increase gastric bleeding
3. Antidepressants-important role
4. Antidepressants increase gastric bleeding
5. Antidepressants could pose grave implications
6. Antidepressant Helps Relieve Hot Flashes
7. Antidepressants May Benefit Heart Patients
8. Antidepressants Harmful for Kids
9. Antidepressants For Children: How safe is it ?
10. Antidepressants Late In Pregnancy Harmful to Unborn Baby
11. Antidepressants Could Lead To Abnormal Bleeding
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: